Makena Pricing Raises Ire Of Maternal Health Advocacy Groups
This article was originally published in The Pink Sheet Daily
Executive Summary
Ther-Rx' pricing for Makena - which could total $30,000 for a series of treatments to prevent preterm labor - is drawing criticism from maternal health advocates and Sen. Sherrod Brown.
You may also be interested in...
Makena Pricing Prompts Multi-Pronged Appeals: FDA, FTC – Bayh-Dole?
The uproar among insurers, physicians and patient groups over the relatively high price of KV Pharmaceutical’s new injectable treatment for preventing preterm births, Makena, has elicited appeals to FDA and the Federal Trade Commission for intervention.
Makena Pricing Prompts Multi-Pronged Appeals: FDA, FTC – Bayh-Dole?
The uproar among insurers, physicians and patient groups over the relatively high price of KV Pharmaceutical’s new injectable treatment for preventing preterm births, Makena, has elicited appeals to FDA and the Federal Trade Commission for intervention.
Former KV Pharmaceutical CEO Sentenced To 30 Days In Jail
Marc Hermelin pleads guilty to distributing oversized morphine sulfate tablets; he may be first pharma exec to be jailed for healthcare fraud.